Literature DB >> 24907563

Aldosterone signaling and soluble adenylyl cyclase-a nexus for the kidney and vascular endothelium.

Boris Schmitz1, Stefan-Martin Brand2, Eva Brand3.   

Abstract

The steroid hormone aldosterone regulates the reabsorption of water and ions in the kidney and plays a central role in blood pressure regulation and homeostasis. In recent years, the vascular endothelium has been established as an important aldosterone target organ with major implications in renal and cardiovascular health and disease. Different lines of evidence suggest that the calcium- and bicarbonate-activated soluble adenylyl cyclase (sAC) is a novel mediator of aldosterone signaling in both the kidney and vascular endothelium. This review summarizes our current understanding of the molecular mechanisms of sAC gene expression regulation in the kidney and vascular endothelium and outlines the potential clinical implications of sAC in chronic kidney disease and cardiovascular disease. This review is part of a special issue entitled: The role of soluble adenylyl cyclase in health and disease. This article is part of a Special Issue entitled: The role of soluble adenylyl cyclase in health and disease.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bicarbonate; Endothelial stiffness; Gene expression; Spironolactone; cAMP

Mesh:

Substances:

Year:  2014        PMID: 24907563     DOI: 10.1016/j.bbadis.2014.05.036

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Plasma renin levels are associated with cardiac function in primary adrenal insufficiency.

Authors:  Peter Wolf; Hannes Beiglböck; Paul Fellinger; Lorenz Pfleger; Stefan Aschauer; Alois Gessl; Rodrig Marculescu; Siegfried Trattnig; Alexandra Kautzky-Willer; Anton Luger; Yvonne Winhofer; Martin Krššák; Michael Krebs
Journal:  Endocrine       Date:  2019-06-08       Impact factor: 3.633

2.  Micro- and macrovascular function in patients suffering from primary adrenal insufficiency: a cross-sectional case-control study.

Authors:  M Müller; H Beiglböck; P Fellinger; Y Winhofer; A Luger; M Gschwandtner; A Willfort-Ehringer; R Koppensteiner; A Kautzky-Willer; M Krebs; O Schlager; P Wolf
Journal:  J Endocrinol Invest       Date:  2020-06-01       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.